Data / Form D filings / Mosaic Biosciences, Inc.
Mosaic Biosciences, Inc.: Form D filings
Mosaic Biosciences, Inc., a biotechnology company in Boulder, CO, filed 3 Form D notices with the SEC between 2011 and 2023. The latest, on January 6, 2023, reports $11.4 million sold of a $11.4 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2830 Wilderness Place, Boulder, CO, 80301
- Phone
- (720) 535-8427
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1526054
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 6, 2023 | New notice | $11,383,000 | $11,382,997 | $3 | 4 | Apr 4, 2022 | sec.gov |
| Feb 10, 2014 | New notice | $2,310,000 | $2,274,000 | $36,000 | 4 | Jan 28, 2014 | sec.gov |
| Jul 20, 2011 | New notice | $1,030,462 | $1,030,462 | 7 | Jul 7, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Rob Capone | Director | |
| Jeanette Welsh | Director | |
| Dan Mitchell | Director | |
| Martin Stanton | Executive Officer, Director | |
| Eric Furfine | Director |
Other biotechnology companies in Colorado that filed recently
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
- Shiverbright Technologies, Inc. $200,000 · Aug 7, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Mosaic Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.